Skip to main content
Clinical Trials/JPRN-UMIN000021557
JPRN-UMIN000021557
Completed
Phase 2

A phase II clinical trial of Carbon-ion therapy for patients with bone and soft tissue sarcomas not suited for surgical resection - Carbon-ion radiotherapy for inoperative bone and soft tissue sarcomas (iROCK-1503BS)

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization0 sites0 target enrollmentMarch 24, 2016

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Bone and soft tissue tumor
Sponsor
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This clinical trial was terminated for reasons of the facility.

Registry
who.int
Start Date
March 24, 2016
End Date
August 24, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Primary cranial tumor 2\) Past history of radiotherapy for the target lesion 3\) Ongoing chemotherapy or within 2 weeks after completion of the chemotherapy 4\) Patient with active double cancer 5\) Patient with active and intractable infection in the target lesion 6\) Patient with artifacts which influence the calculation of irradiation dose 7\) Other medical or psychological condition which is unsuitable for carbon\-ion therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials